MedlineFRA:L10 +5.16%14 Pretax Margin % is 3.96% as of Mar. 2026, which is 43% above its 10-year median of 2.77. GuruFocus rates FRA:L10 with a GF Score™ of 14/100. The stock has 3 warning signs investors should review. Among 818 Medical Devices & Instruments companies, Medline ranks better than 52.93% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Medline's Pre-Tax Income for the
three
months ended in Mar. 2026 was €252 Mil. Medline's Revenue for the
three
months ended in Mar. 2026 was €6,359 Mil. Therefore, Medline's pretax margin for the quarter that ended in Mar. 2026 was 3.96%.
The historical rank and industry rank for Medline's Pretax Margin % or its related term are showing as below:
FRA:L10'
s Pretax Margin % Range Over the Past 10 Years
Min: 0.05 Med: 2.77 Max: 4.88
Current: 4.12
FRA:L10's Pretax Margin % is ranked better than 52.93% of 818
companies
in the Medical Devices & Instruments industry
Industry Median: 2.505
vs FRA:L10: 4.12
Medline (FRA:L10) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Medline Pretax Margin % Related Terms
Medline Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Medline's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:L10 vs RMD, WST, BDX: Pretax Margin % Comparison
For the Medical Instruments & Supplies subindustry, Medline's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medline Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medline's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Medline's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medline (FRA:L10) has a Pretax Margin % of 3.96% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Medline and its competitors. This is 43% above median its historical median of 2.77. Over the past decade, Medline's Pretax Margin % has ranged from 0.05 to 4.88. According to the industry distribution chart, Medline ranks #385 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 47.1%.
Is Medline's Pretax Margin % too high?
Medline's current Pretax Margin % of 3.96% is 43% above median its 10-year median of 2.77. Over the past 10 years, this metric has ranged from a low of 0.05 to a high of 4.88. The Medical Devices & Instruments industry median Pretax Margin % is 2.51. Medline's value of 3.96% is 58.1% above this industry median. Based on the distribution chart, Medline ranks #385 out of 818 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medline has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Medline's Pretax Margin % compare to RMD and WST?
According to the Medical Devices & Instruments industry distribution chart, Medline ranks #385 out of 818 companies for Pretax Margin %. This puts Medline in the upper half of its industry. The industry median Pretax Margin % is 2.51. Medline's value of 3.96% is 58.1% above this benchmark. Historically, Medline's own Pretax Margin % has ranged from 0.05 to 4.88 over the past decade. While the company's 10-year median is 2.77 vs. the industry median of 2.51, Medline has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.51, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medline's current Pretax Margin % of 3.96% is 58.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Medline and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medline's current Pretax Margin % is 3.96%, which is 43% above median its own 10-year median of 2.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medline stock overvalued right now?
Medline (FRA:L10) has a current Pretax Margin % of 3.96%. The current Pretax Margin % is 3.96%, which is 43% above median its 10-year median of 2.77 and 58.1% above the Medical Devices & Instruments industry median of 2.51. Medline's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Medline (FRA:L10), the current Pretax Margin % is 3.96% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
14GF Score
Get the complete analysis for FRA:L10
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L10 has been successfully added to your 
